Evidence map›Paper›PMID 31212796›Full record

ArticleCancers2019

Comprehensive Profiling of Primary and Metastatic ccRCC Reveals a High Homology of the Metastases to a Subregion of the Primary Tumour.

Paranita Ferronika, Joost Hof, Gursah Kats-Ugurlu, Rolf H Sijmons, Martijn M Terpstra, Kim de Lange, Annemarie Leliveld-Kors, Helga Westers, Klaas Kok

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Paranita FerronikaDepartment of Genetics, University of Groningen, University Medical Center Groningen, HPC CB50, 9700 RB Groningen, The Netherlands. p.ferronika@umcg.nl.ORCID 0000-0001-7881-7924
Joost HofDepartment of Genetics, University of Groningen, University Medical Center Groningen, HPC CB50, 9700 RB Groningen, The Netherlands. j.hof01@umcg.nl.ORCID 0000-0002-8904-096X
Gursah Kats-UgurluDepartment of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, HPC EA10, 9700 RB Groningen, The Netherlands. g.kats-ugurlu@umcg.nl.
Rolf H SijmonsDepartment of Genetics, University of Groningen, University Medical Center Groningen, HPC CB50, 9700 RB Groningen, The Netherlands. r.h.sijmons@umcg.nl.
Martijn M TerpstraDepartment of Genetics, University of Groningen, University Medical Center Groningen, HPC CB50, 9700 RB Groningen, The Netherlands. m.m.terpstra.cluster@gmail.com.
Kim de LangeDepartment of Genetics, University of Groningen, University Medical Center Groningen, HPC CB50, 9700 RB Groningen, The Netherlands. k.de.lange@umcg.nl.
Annemarie Leliveld-KorsDepartment of Urology, University of Groningen, University Medical Center Groningen, HPC CB60, 9700 RB Groningen, The Netherlands. a.m.leliveld@umcg.nl.
Helga WestersDepartment of Genetics, University of Groningen, University Medical Center Groningen, HPC CB50, 9700 RB Groningen, The Netherlands. h.westers@umcg.nl.ORCID 0000-0001-8291-5949
Klaas KokDepartment of Genetics, University of Groningen, University Medical Center Groningen, HPC CB50, 9700 RB Groningen, The Netherlands. k.kok@umcg.nl.ORCID 0000-0001-8655-3439
University Medical Center Groningen · NL

Funding

Nuffic NFP-PhD.13/ 119
6 · The paper itself

Abstract

While intratumour genetic heterogeneity of primary clear cell renal cell carcinoma (ccRCC) is well characterized, the genomic profiles of metastatic ccRCCs are seldom studied. We profiled the genomes and transcriptomes of a primary tumour and matched metastases to better understand the evolutionary processes that lead to metastasis. In one ccRCC patient, four regions of the primary tumour, one region of the thrombus in the inferior vena cava, and four lung metastases (including one taken after pegylated (PEG)-interferon therapy) were analysed separately. Each sample was analysed for copy number alterations and somatic mutations by whole exome sequencing. We also evaluated gene expression profiles for this patient and 15 primary tumour and 15 metastasis samples from four additional patients. Copy number profiles of the index patient showed two distinct subgroups: one consisted of three primary tumours with relatively minor copy number changes, the other of a primary tumour, the thrombus, and the lung metastases, all with a similar copy number pattern and tetraploid-like characteristics. Somatic mutation profiles indicated parallel clonal evolution with similar numbers of private mutations in each primary tumour and metastatic sample. Expression profiling of the five patients revealed significantly changed expression levels of 57 genes between primary tumours and metastases, with enrichment in the extracellular matrix cluster. The copy number profiles suggest a punctuated evolution from a subregion of the primary tumour. This process, which differentiated the metastases from the primary tumours, most likely occurred rapidly, possibly even before metastasis formation. The evolutionary patterns we deduced from the genomic alterations were also reflected in the gene expression profiles.

Indexed as

copy number alterationgene expressionintratumour heterogeneitymetastatic ccRCCmutation

Identifiers

PMID31212796
PMCPMC6628027
OpenAlexW2952247036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.